DAS
CSTL icon

Diversify Advisory Services’s Castle Biosciences CSTL Stock Holding History

Diversify Advisory Services’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,498
Closed -$278K – 658
2024
Q1 		$278K Buy
+12,498
New +$272K 0.02% 547

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Diversify Advisory Services's CSTL Position: Q2 2024 in Review

Diversify Advisory Services sold out of Castle Biosciences (CSTL) in Q2 2024, closing a stake of 12,498 shares — an estimated $278K sold.

Diversify Advisory Services first reported a position in CSTL in Q1 2024 and held it in 1 quarter. The position peaked at $278K in Q1 2024. 159 funds tracked by Wall St. Rank hold CSTL as of Q2 2024.

  • Diversify Advisory Services reported no remaining Castle Biosciences position as of Q2 2024 after selling out during the quarter.
  • Diversify Advisory Services sold 12,498 Castle Biosciences shares in Q2 2024, an estimated $278K.
  • Diversify Advisory Services first reported a position in Castle Biosciences in Q1 2024 and held it in 1 quarter.
  • Diversify Advisory Services's Castle Biosciences position peaked at $278K in Q1 2024.
  • 159 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2024.

Based on Diversify Advisory Services's 13F filing for Q2 2024, filed 12 Jul 2024.